SEARCH

SEARCH BY CITATION

References

  • 1
    Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889895.
  • 2
    Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson E M & French FS (1995) Androgen receptor defects: historical, clinical, & molecular perspectives. Endocr Rev 16, 271321.
  • 3
    Brinkmann AO (2001) Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179, 105109.
  • 4
    Heinlein CA & Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25, 276308.
  • 5
    Heemers HV & Tindall DJ (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28, 778808.
  • 6
    McEwan IJ (2009) Nuclear receptors: one big family. Methods Mol Biol 505, 318.
  • 7
    Tilley WD, Buchanan G, Hickey TE & Bentel JM (1996) Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 2, 277285.
  • 8
    Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH & Kantoff PW (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1, 33203323.
  • 9
    Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA & Ostrander EA (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57, 11941198.
  • 10
    Wang C & Uchida T (1997) Androgen receptor gene mutations in prostate cancer. Nippon Hinyokika Gakkai Zasshi 88, 550556.
  • 11
    Gottlieb B, Beitel LK, Lumbroso R, Pinsky L & Trifiro M (1999) Update of the androgen receptor gene mutations database. Hum Mutat 14, 103114.
  • 12
    Gottlieb B, Beitel LK, Wu J, Elhaji YA & Trifiro M (2004) Nuclear receptors and disease: androgen receptor. Essays Biochem 40, 121136.
  • 13
    Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M, Gottlieb B, Beitel LK, Nadarajah A, Paliouras M & Trifiro M (2012) The androgen receptor gene mutations database: 2012 update. Hum Mutat 33, 887894.
  • 14
    Linja MJ & Visakorpi T (2004) Alterations of androgen receptor in prostate cancer. J Steroid Biochem Mol Biol 92, 255264.
  • 15
    Kumar R, Atamna H, Zakharov MN, Bhasin S, Khan SH & Jasuja R (2011) Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy. Life Sci 88, 565571.
  • 16
    Hay CW & McEwan IJ (2012) The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity. PLoS One 7, e32514.
  • 17
    Marcelli M, Zoppi S, Grino PB, Griffin JE, Wilson JD & Mcphaul MJ (1991) A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. J Clin Invest 87, 11231126.
  • 18
    Kawate H, Wu Y, Ohnaka K, Tao R, Nakamura K, Okabe T, Yanase T, Nawata H & Takayanagi R (2005) Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients. J Clin Endocrinol Metab 90, 61626169.
  • 19
    Jääskeläinen J (2012) Molecular biology of androgen insensitivity. Mol Cell Endocrinol 352, 412.
  • 20
    Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA & Stratton MR (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2, 132134.
  • 21
    Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron JF, Pujol H & Sultan C (1993) Male breast cancer and the androgen receptor gene. Nat Genet 5, 109110.
  • 22
    La Spada AR, Wilson EM, Lubahn DB, Harding AE & Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 7779.
  • 23
    Becker M, Martin E, Schneikert J, Krug HF & Cato ACB (2000) cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J Cell Biol 149, 255262.
  • 24
    Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG & Sawyers CL (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med 10, 3339.
  • 25
    Lamont KR & Tindall DJ (2011) Minireview: alternative activation pathways for the androgen receptor in prostate cancer. Mol Endocrinol 25, 897907.
  • 26
    Glass CK & Rosenfeld MG (2000) Coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14, 121141.
  • 27
    Lonard DM, Lanz RB & O'Malley BW (2007) Nuclear receptor coregulators and human disease. Endocr Rev 28, 575587.
  • 28
    Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C & Haelens A (2008) Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal 27, e008.
  • 29
    Li J & Al-Azzawi F (2009) Mechanism of androgen receptor action. Maturitas 63, 142148.
  • 30
    Wang C, Tian L, Popov VM & Pestell RG (2011) Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol 123, 91100.
  • 31
    Li J, Fu J, Toumazou C, Yoon HG & Wong J (2006) A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin. Mol Endocrinol 20, 776785.
  • 32
    Klokk TI, Kurys P, Elbi C, Nagaich AK, Hendarwanto A, Slagsvold T, Chang CY, Hager GL & Saatcioglu F (2007) Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol 27, 18231843.
  • 33
    Centenera MM, Harris JM, Tilley WD & Butler LM (2008) The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol Endocrinol 22, 23732382.
  • 34
    Jenster G, van der Korput JA, Trapman J & Brinkmann AO (1992) Functional domains of the human androgen receptor. J Steroid Biochem Mol Biol 41, 671675.
  • 35
    Jenster G, Trapman J & Brinkmann AO (1993) Nuclear import of the human androgen receptor. Biochem J 293, 761768.
  • 36
    Zhou ZX, Sar M, Simental JA, Lane MV & Wilson EM (1994) A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem 269, 1311513123.
  • 37
    Robbins J, Dilworth SM, Laskey RA & Dingwall C (1991) Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64, 615623.
  • 38
    Hodel MR, Corbett AH & Hodel AE (2001) Dissection of a nuclear localization signal. J Biol Chem 276, 13171325.
  • 39
    Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ & Lefebvre YA (1999) Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19, 10251037.
  • 40
    Freedman ND & Yamamoto KR (2004) Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell 15, 22762286.
  • 41
    Poukka H, Karvonen U, Yoshikawa N, Tanaka H, Palvimo JJ & Janne OA (2000) The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J Cell Sci 113, 29913001.
  • 42
    Kaku N, Matsuda K, Tsujimura A & Kawata M (2008) Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5′-triphosphate systems. Endocrinology 149, 39603969.
  • 43
    Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B & Roy AK (2000) Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol 14, 11621174.
  • 44
    Black BE & Paschal BM (2004) Intranuclear organization and function of the androgen receptor. Trends Endocrinol Metab 15, 411417.
  • 45
    Shank LC & Paschal BM (2005) Nuclear transport of steroid hormone receptors. Crit Rev Eukaryot Gene Expr 15, 4973.
  • 46
    Kumar S, Saradhi M, Chaturvedi NK & Tyagi RK (2006) Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol Cell Endocrinol 246, 147156.
  • 47
    Stewart M (2007) Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 8, 195208.
  • 48
    van Royen ME, Cunha SM, Brink MC, Mattern KA, Nigg AL, Dubbink HJ, Verschure PJ, Trapman J & Houtsmuller AB (2007) Compartmentalization of androgen receptor protein–protein interactions in living cells. J Cell Biol 177, 6372.
  • 49
    Cutress ML, Whitaker HC, Mills IG, Stewart M & Neal DE (2008) Structural basis for the nuclear import of the human androgen receptor. J Cell Sci 121, 957968.
  • 50
    Macara IG (2001) Transport into and out of the nucleus. Microbiol Mol Biol Rev 65, 570594.
  • 51
    Kumar S, Chaturvedi NK, Nishi M, Kawata M & Tyagi RK (2004) Shuttling components of nuclear import machinery involved in nuclear translocation of steroid receptors exit nucleus via exportin-1/CRM-1* independent pathway. Biochim Biophys Acta 1691, 7377.
  • 52
    Zoppi S, Marcelli M, Deslypere JP, Griffin JE, Wilson JD & McPhaul MJ (1992) Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol Endocrinol 6, 409415.
  • 53
    Nazareth LV, Stenoien DL, Bingman WE III, James AJ, Wu C, Zhang Y, Edwards DP, Mancini M, Marcelli M, Lamb DJ & Weigel NL (1999) A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Mol Endocrinol 13, 20652075.
  • 54
    Thomas M, Dadgar N, Aphale A, Harrell JM, Kunkel R, Pratt WB & Lieberman AP (2004) Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts. J Biol Chem 279, 83898395.
  • 55
    Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML & Pestell RG (2000) p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 275, 2085320860.
  • 56
    Fu M, Wang C, Wang J, Zhang X, Sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua SA, Jaffray E, Hay RT, Palvimo JJ, Jänne OA & Pestell RG (2002) Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol 22, 33733388.
  • 57
    Gaughan L, Logan IR, Cook S, Neal DE & Robson CN (2002) Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J Biol Chem 277, 2590425913.
  • 58
    Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C, Fan S, Rosen E, Palvimo JJ, Jänne OA, Muratoglu S, Avantaggiati ML & Pestell RG (2003) Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23, 85638575.
  • 59
    Haelens A, Tanner T, Denayer S, Callewaert L & Claessens F (2007) The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor. Cancer Res 67, 45144523.
  • 60
    Faus H & Haendler B (2008) Androgen receptor acetylation sites differentially regulate gene control. J Cell Biochem 104, 511524.
  • 61
    Tanner TM, Denayer S, Geverts B, Van Tilborgh N, Kerkhofs S, Helsen C, Spans L, Dubois V, Houtsmuller AB, Claessens F & Haelens A (2010) A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels. Cell Mol Life Sci 67, 19191927.
  • 62
    Clinckemalie L, Vanderschueren D, Boonen S & Claessens F (2012) The hinge region in androgen receptor control. Mol Cell Endocrinol 358, 18.
  • 63
    Kumar S, Saradhi M, Chaturvedi NK & Tyagi RK (2012) Retention and transmission of active transcription memory from progenitor to progeny cells via ligand-modulated transcription factors: elucidation of a concept by Biopit Model. Cell Biol Int 36, 177182.
  • 64
    Kumar S, Chaturvedi NK, Kumar S & Tyagi RK (2008) Agonist-mediated docking of androgen receptor onto the mitotic chromatin platform discriminates intrinsic mode of action of prostate cancer drugs. Biochim Biophys Acta 1783, 5973.
  • 65
    Saradhi M, Sengupta A, Mukhopadhyay G & Tyagi RK (2005) Pregnane and Xenobiotic Receptor (PXR/SXR) resides predominantly in the nuclear compartment of the interphase cell and associates with the condensed chromosomes during mitosis. Biochim Biophys Acta 1746, 8594.
  • 66
    Sarge KD & Park-Sarge OK (2009) Mitotic bookmarking of formerly active genes: keeping epigenetic memories from fading. Cell Cycle 8, 818823.
  • 67
    Chaturvedi NK, Kumar S, Negi S & Tyagi RK (2010) Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders. Mol Cell Biochem 345, 291308.
  • 68
    Zaidi SK, Young DW, Montecino MA, Lian JB, van Wijnen AJ, Stein JL & Stein GS (2010) Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat Rev Genet 11, 583589.
  • 69
    Nakauchi H, Matsuda K, Ochiai I, Kawauchi A, Mizutani Y, Miki T & Kawata M (2007) A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines. J Histochem Cytochem 55, 535544.
  • 70
    Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, Weigel NL, Moran T, Mikic I, Price JH & Mancini MA (2006) Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem 98, 770788.
  • 71
    Farla P, Hersmus R, Geverts B, Mari PO, Nigg AL, Dubbink HJ, Trapman J & Houtsmuller AB (2004) The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. J Struct Biol 147, 5061.
  • 72
    van Royen ME, van Cappellen WA, de Vos C, Houtsmuller AB & Trapman J (2012) Stepwise androgen receptor dimerization. J Cell Sci 125, 12701279.
  • 73
    Tahara K, Takagi M, Ohsugi M, Sone T, Nishiumi F, Maeshima K, Horiuchi Y, Tokai-Nishizumi N, Imamoto F, Yamamoto T, Kose S & Imamoto N (2008) Importin-beta and the small guanosine triphosphatase Ran mediate chromosome loading of the human chromokinesin Kid. J Cell Biol 180, 493506.
  • 74
    Jochum T, Ritz ME, Schuster C, Funderburk SF, Jehle K, Schmitz K, Brinkmann F, Hirtz M, Moss D & Cato AC (2012) Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures. Biochim Biophys Acta 1822, 10701078.